99P Real-world management of ir-colitis: A Danish 10-year cohort study
Immune checkpoint inhibitors (CPI) induced diarrhoea and colitis (ir-colitis) are common immune-related adverse events. Ir-colitis management guidelines are based on expert consensus. This retrospective study presents real-world data on melanoma patients with ir-colitis requiring medical intervention. The objective was to describe treatment patterns, hypothesising that glucocorticoid (GC) use exceeds guidelines and that biologic treatment (BIOx) initiation is often delayed.
Authors
- Christina H. Bruvik Ruhlmann (ORCID: https://orcid.org/0000-0002-3728-273X)
- S.K. Petersen (ORCID: https://orcid.org/0000-0001-8276-4335)
- Jens Kjeldsen (ORCID: https://orcid.org/0000-0001-8148-6572)
- Lars Bastholt (ORCID: https://orcid.org/0000-0001-5478-9826)
- S. Madley
Institutions
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.iotech.2024.100842
- Citations
- 1
- Primary Topic
- Microscopic Colitis
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Novo Nordisk Fonden